Item 7.01. Regulation FD Disclosure.
As previously reported on a Form 8-K filed
by Nuo Therapeutics, Inc. (the “Company”), on January 26, 2016, the Company filed a voluntary petition in the United
States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) seeking relief under Chapter 11 of Title
11 of the United States Code (the “Bankruptcy Code”), which is being administered under the caption “In re: Nuo
Therapeutics, Inc.”, Case No. 16-10192 (MFW) (the “Chapter 11 Case”). On May 5, 2016 (the “Effective Date”),
the Company's Modified First Amended Plan of Reorganization (as confirmed, the “Plan”) went effective under the terms
applicable to “Scenario A” as set forth in the Plan, as reported on a Form 8-K filed on May 10, 2016.
On August 22, 2016, the Company filed its
unaudited Quarterly Operating Report for the period between the Effective Date and June 30, 2016 (the “Quarterly Operating
Report”) with the Bankruptcy Court. The financial statements in the Quarterly Operating Report were not audited, were not
prepared in accordance with accounting principles generally accepted in the United States and are in a format prescribed by applicable
bankruptcy laws and regulations. The Company cautions investors and potential investors not to place undue reliance on the information
contained in the Quarterly Operating Report, which was not prepared for the purpose of providing the basis for an investment decision
relating to any of the securities of the Company. The Quarterly Operating Report has been prepared solely for the purpose of complying
with the reporting requirements of the Office of the United States Trustee. The Quarterly Operating Report is limited in scope
and only covers a limited time period.
There can be no assurance that, from the
perspective of an investor or potential investor in the Company’s securities, the Quarterly Operating Report is complete.
The Quarterly Operating Report may be subject to future adjustment and reconciliation. The Quarterly Operating Report also contains
information for periods which are shorter or otherwise different from those required in the Company’s reports pursuant to
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and such information might not be indicative
of the Company’s financial condition or operating results for the period that would be reflected in the Company’s financial
statements or in its reports pursuant to the Exchange Act. The information set forth in the Quarterly Operating Report should not
be viewed as indicative of future results
A copy of this Quarterly Operating Report
is attached as Exhibit 99.1 hereto and incorporated herein by reference. The Quarterly Operating Report annexed as Exhibit 99.1
hereto shall not be deemed an admission as to the materiality of any information disclosed therein.
The Company notes that trading in its pre-bankruptcy
shares of common stock (the “Old Shares”) has ceased, and such Old Shares were cancelled in their entirety as of the
Effective Date. Subject to the terms of the Plan, record holders of Old Shares have been issued new shares of the Company's common
stock ( “New Shares”), provided such holders submitted the necessary documentation (including release) in accordance
with the terms of the Plan.
The New Shares are not yet eligible for
trading on an OTC market. The Company is working diligently with its advisors to become current in its periodic reporting obligations
under the Exchange Act, to apply for and obtain FINRA approval for trading of the New Shares, and to obtain eligibility through
the Depository Trust Company for electronic distribution of the New Shares to brokerage accounts.
Cautionary Statement Regarding Forward-Looking Statements
The statements contained in this
Current Report on Form 8-K that are not purely historical are forward-looking statements within the meaning of Section 27A
of the Securities Act of 1933 and Section 31E of the Securities Exchange Act of 1934, including statements regarding the Company’s
expectations, hopes, beliefs, intentions, or strategies regarding the future, including without limitation its expectations with
respect to becoming current in its periodic reporting obligations, applying for and obtaining FINRA approval for trading of the
New Shares, and obtaining eligibility through the Depository Trust Company for electronic distribution of the New Shares to brokerage
accounts. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance
and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking
statements as a result of various factors. All forward-looking statements included in this document are based on information available
to the Company on the date hereof and the Company assumes no obligation to update any such forward-looking statement. Prospective
investors should also consult the risks described from time to time in the Company’s Reports on Forms 10-K, 10-Q and
8-K and Annual Reports to Shareholders.
Limitation on Incorporation by Reference
In accordance with General Instruction B.2
of Form 8-K, the information in this Item 7.01 is being furnished for informational purposes only and shall not be deemed “filed”
for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information
be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as otherwise expressly stated
in such filing. The filing of this Form 8-K shall not be deemed an admission as to the materiality of any information herein that
is required to be disclosed solely by Regulation FD.